🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very nice work by Karlo Toljan and the entire CAVS-MS team Pascal Sati Russell Shinohara Daniel Reich We will see similar results from nikosevangelou3 and DECISIVE soon! This data was used to get CVS into the McDonald criteria!

It is a tremendous honor, something I could not expect at all back in 1999 when I attended my first ECTRIMS meeting. It is a huge responsibility & a lot of work ahead. I hope to serve you all in the best way possible. Many thanks to Mar Tintore & Xavier Montalban (Pic Neus Mongay-Ochoa )

"It is going to open the umbrella up to who can be diagnosed with MS in a very substantial way." -- Daniel Ontaneda, of Cleveland Clinic, discussing revisions to the McDonald diagnostic criteria for multiple sclerosis. ECTRIMS #ECTRIMS2024 MedPage Neurology medpagetoday.com/meetingcoverag…

Excelente exposición de Daniel Ontaneda sobre #EsclerosisMultiple , patogénesis y tratamientos actuales. Inmenso y apasionante el mundo de la neurounmunologia #CongresoEcuatorianoNeurología

Throughout the years, the European Charcot Foundation, thanks to Prof G Comi, has established a strong presence, deeply rooted and full of vitality. ECF remains committed to its mission of raising global awareness about #MS and supporting organizations that share this mision. #MSinitiatives

"•[Central vein sign] can be incorporated in radiological 2017 #McDonald diagnostic criteria. •Requirement of 1 lesion with #CVS can increase specificity and accuracy. •Subcortical lesions with CVS can potentially be used to increase sensitivity." Moein Amin Daniel Ontaneda

We mourn the loss of Prof. Giancarlo Comi, a pioneering neurologist in multiple sclerosis research. As a former ECTRIMS council member and European Charcot Foundation (European Charcot Foundation) founder, his contributions have profoundly shaped the field and patient care globally.

We mourn the loss of Prof Giancarlo Comi, a pioneering neurologist who advanced MS research and care. As a founding leader of ECF and ACTRIMS partner since 2020, his visionary work shaped neurology and patient care. Our condolences to his loved ones. His legacy inspires us all.

Happy to have organized this Special Issue with @MironLab in MSJ from selected topics from ACTRIMS® Forum 2024, Breaking Barriers in MS. Thanks to all the authors and happy to have gotten it all done in 2024! 😀 journals.sagepub.com/toc/msja/30/5_…

We’re excited to announce a special issue of the Multiple Sclerosis Journal titled "Breaking Barriers in MS," organized by our 2024 Forum Scientific Program Chairs, Daniel Ontaneda and @MironLab. Read this special issue here: journals.sagepub.com/toc/msja/30/5_…

In Hispanic/Latinx Americans the age at onset of #MultipleSclerosis is earlier and the initial progressive disease course is more common, compared with non-Hispanic White Americans. Study from Daniel Ontaneda Miller Medicine Cleveland Clinic ▶️ journals.sagepub.com/doi/abs/10.117…

Check out our recent work published in Neurology Journal , where we explored the role of spinal cord reserve in a multicenter European cohort of people with MS Jaume Sastre-Garriga D.Pareto Alex Rovira Cemcat Neuroradiology Hospital Vall d'Hebron. MAGNIMS 👇🧵neurology.org/doi/10.1212/WN…

The last beam is up at the home of our new neurological institute building! Cleveland Clinic Cleveland Clinic MD Turner Construction Hopkins Architects

"In this special issue of the International Journal of #MultipleSclerosis Care (IJMSC), "Comprehensive MS Care: A #Global Perspective," we aim to provide a snapshot of MS care across the globe and in different populations." Guest Editor Daniel Ontaneda doi.org/10.7224/1537-2…

Lots of work went into this one! Understanding the spinal cord will help us better target progression. great work Kedar Mahajan Cleveland Clinic Neurodegeneration and Demyelination in the MS Spinal Cord: Clinical, Pathological, and 7T MRI Perspectives hubs.la/Q03c-9HP0

We have secured an award to follow DELIVER-MS participants 9 years out! Thankful to PCORI, our participants and investigators. huge joint effort with emma tallantyre and nikosevangelou3 lerner.ccf.org/news/article/?…

Congratulations to Karlo Toljan for a successful defense of his PhD. An honor to be his advisor. Getting a PhD in Residency and Fellowship is no small feat 5 papers will come from his thesis. Important work that helped get CVS in DXcriteria Cleveland Clinic A. Blake Buletko, MD Cleveland Clinic Neurology Residents

Don’t miss this afternoon’s educational session at #ASNR25. Updated 2024 McDonald Criteria for Multiple Sclerosis & new imaging markers #CVS & #PRL with ⁦Jae Song⁩ ⁦Daniel Reich⁩ ⁦Daniel Ontaneda⁩ ⁦Pascal Sati⁩ ⁦Marcel Maya⁩

Excited to welcome Dr. Jamie Holloman brainboyneurology as new co-host of the #MSLivingWell podcast! 🎙️ 1st episode! Secondary Progressive MS: Next Chapter 🍎 apple.co/4jddhRk 🎧 bit.ly/4j8wh3D Moein Amin Alise Carlson Daniel Ontaneda Mary Rensel MD FAAN ABIHM #neurotwitter

XII MEXCTRIMS National Congress: presentation of national guidelines for MS (Irene Treviño Frenk and others), moving homage to Giancarlo Comi, and review of the 2024 McDonald criteria by Prof. Hartung (overall), L. Leocani (visual pathway), MRI (Daniel Ontaneda) and CSF (Georgina Arrambide).